The Beauty Health Company (NASDAQ:SKIN) Receives $2.02 Average Target Price from Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have been assigned an average rating of “Hold” from the eight analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $2.02.

Several research firms have weighed in on SKIN. Roth Capital reiterated a “buy” rating and set a $2.00 target price (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th. Canaccord Genuity Group lowered their price target on Beauty Health from $1.50 to $1.00 and set a “hold” rating for the company in a report on Friday, May 1st. Zacks Research lowered Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday. Finally, Weiss Ratings upgraded Beauty Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, July 8th.

Beauty Health Trading Down 0.9%

SKIN opened at $0.75 on Monday. The firm’s fifty day moving average is $0.73 and its two-hundred day moving average is $0.98. The company has a debt-to-equity ratio of 4.37, a quick ratio of 1.48 and a current ratio of 1.79. The firm has a market cap of $97.81 million, a PE ratio of -4.44 and a beta of 1.08. Beauty Health has a twelve month low of $0.55 and a twelve month high of $2.69.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.04. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. The company had revenue of $64.91 million during the quarter, compared to analyst estimates of $66.28 million. Equities research analysts anticipate that Beauty Health will post -0.16 EPS for the current year.

Institutional Trading of Beauty Health

Several hedge funds have recently bought and sold shares of the stock. Bank of America Corp DE lifted its stake in Beauty Health by 19.2% in the first quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock valued at $95,000 after buying an additional 17,088 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Beauty Health by 29.6% during the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock worth $253,000 after acquiring an additional 64,900 shares in the last quarter. Capricorn Fund Managers Ltd acquired a new stake in shares of Beauty Health during the first quarter worth $17,270,000. Diversified Trust Co acquired a new stake in shares of Beauty Health during the first quarter worth $25,000. Finally, Invesco Ltd. raised its holdings in shares of Beauty Health by 65.4% during the fourth quarter. Invesco Ltd. now owns 69,422 shares of the company’s stock worth $96,000 after acquiring an additional 27,453 shares during the period. 93.26% of the stock is currently owned by institutional investors and hedge funds.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.